Zobrazeno 1 - 10 of 218 pro vyhledávání: '"Wd, Tilley"'
1
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor
Autor: Jj, Park, Ra, Irvine, Buchanan G, Ss, Koh, Jm, Park, Wd, Tilley, Stallcup MR, Mf, Press, Gerhard Coetzee
Publikováno v: Europe PubMed Central
In the present study, the role of BRCA1 in ligand-dependent androgen receptor (AR) signaling was assessed. In transfected prostate and breast cancer cell lines, BRCA1 enhanced AR-dependent transactivation of a probasin-derived reporter gene. The effe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c43974673127a40efd8976e2a3b863e9
https://pubmed.ncbi.nlm.nih.gov/11085509
Zobrazit plný text záznamu
2
Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer
Autor: Ricciardelli C, David Quinn, Wa, Raymond, McCaul K, Pd, Sutherland, Pd, Stricker, Jj, Grygiel, Rl, Sutherland, Vr, Marshall, Wd, Tilley, Dj, Horsfall
Publikováno v: Europe PubMed Central
The disease course of localized prostate cancer is highly variable, and patients potentially curable by aggressive management are not readily identified by current clinical practice. Chondroitin sulfate (CS) glycosaminoglycan is a candidate biomarker
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8825b63ef22847000f80d7510aa7ac79
http://europepmc.org/abstract/med/10344737
Zobrazit plný text záznamu
3
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
Autor: Rahman R; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Rahaman MH; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Hanson AR; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Choo N; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia., Xie J; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Townley SL; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Shrestha R; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.; Flinders University, Freemasons Centre for Male Health and Wellbeing, Bedford Park, SA, Australia., Hassankhani R; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Islam S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Ramm S; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Simpson KJ; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC, Australia., Risbridger GP; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, Melbourne, VIC, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Best G; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Centenera MM; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Balk SP; Beth Israel Deaconess Medical Center, Boston, MA, USA., Kichenadasse G; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.; Department of Medical Oncology, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, SA, South Australia., Taylor RA; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, Melbourne, VIC, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia.; Biomedicine Discovery Institute Cancer Program, Department of Physiology, Monash University, Clayton, VIC, Australia., Butler LM; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Tilley WD; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Conn SJ; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Lawrence MG; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, Melbourne, VIC, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Wang S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Selth LA; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia. luke.selth@flinders.edu.au.; Flinders University, Freemasons Centre for Male Health and Wellbeing, Bedford Park, SA, Australia. luke.selth@flinders.edu.au.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. luke.selth@flinders.edu.au.
Publikováno v: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1719.
Zobrazit plný text záznamu
4
Akademický článek
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
Autor: Rahman R; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Rahaman MH; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Hanson AR; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Choo N; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia., Xie J; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Townley SL; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Shrestha R; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.; Flinders University, Freemasons Centre for Male Health and Wellbeing, Bedford Park, SA, Australia., Hassankhani R; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Islam S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Ramm S; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Simpson KJ; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC, Australia., Risbridger GP; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, Melbourne, VIC, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Best G; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Centenera MM; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Balk SP; Beth Israel Deaconess Medical Center, Boston, MA, USA., Kichenadasse G; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.; Department of Medical Oncology, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, SA, South Australia., Taylor RA; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, Melbourne, VIC, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia.; Biomedicine Discovery Institute Cancer Program, Department of Physiology, Monash University, Clayton, VIC, Australia., Butler LM; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Tilley WD; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Conn SJ; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia., Lawrence MG; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, Melbourne, VIC, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Wang S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Selth LA; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia. luke.selth@flinders.edu.au.; Flinders University, Freemasons Centre for Male Health and Wellbeing, Bedford Park, SA, Australia. luke.selth@flinders.edu.au.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. luke.selth@flinders.edu.au.
Publikováno v: British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (6), pp. 1092-1105. Date of Electronic Publication: 2024 Aug 08.
Zobrazit plný text záznamu
5
Akademický článek
Are androgen receptor agonists a treatment option in bladder cancer?
Autor: De Ieso ML; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Aldoghachi AF; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Dwyer AR; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia. Electronic address: amy.dwyer@adelaide.edu.au.
Publikováno v: The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2025 Jan; Vol. 245, pp. 106623. Date of Electronic Publication: 2024 Sep 19.
Zobrazit plný text záznamu
6
Akademický článek
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis.
Autor: Shrestha RK; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Nassar ZD; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Hanson AR; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Iggo R; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Institut Bergonié Unicancer, INSERM, Bordeaux, France., Townley SL; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Dehairs J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Mah CY; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Helm M; South Australian Health and Medical Research Institute, Adelaide, Australia., Alizadeh-Ghodsi M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Pickering M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Ghesquière B; Metabolomics Core Facility Leuven, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Watt MJ; Department of Physiology, University of Melbourne, Melbourne, Australia., Quek LE; School of Mathematics and Statistics, Charles Perkins Centre, Faculty of Science, The University of Sydney, Camperdown, Australia., Hoy AJ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Butler LM; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Selth LA; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia.
Publikováno v: Cancer research [Cancer Res] 2024 Jul 15; Vol. 84 (14), pp. 2313-2332.
Zobrazit plný text záznamu
7
Akademický článek
Library size confounds biology in spatial transcriptomics data.
Autor: Bhuva DD; South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5005, Australia. dharmesh.bhuva@adelaide.edu.au.; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia. dharmesh.bhuva@adelaide.edu.au.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia. dharmesh.bhuva@adelaide.edu.au., Tan CW; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia.; The University of Queensland Fraser Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia., Salim A; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Melbourne School of Population and Global Health, School of Mathematics and Statistics, The University of Melbourne, Melbourne, VIC, 3010, Australia., Marceaux C; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia.; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia., Pickering MA; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Chen J; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Kharbanda M; South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5005, Australia.; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Jin X; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Liu N; South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5005, Australia.; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Feher K; South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5005, Australia.; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Putri G; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Asselin-Labat ML; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia.; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia., Phipson B; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia., Davis MJ; South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5005, Australia.; Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia.; The University of Queensland Fraser Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.; Department of Clinical Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia.
Publikováno v: Genome biology [Genome Biol] 2024 Apr 18; Vol. 25 (1), pp. 99. Date of Electronic Publication: 2024 Apr 18.
Zobrazit plný text záznamu
8
Akademický článek
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Autor: Palmieri C; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular, and Integrative Biology, The University of Liverpool, Liverpool, UK. Electronic address: c.palmieri@liverpool.ac.uk., Linden H; Division of Hematology and Oncology, Fred Hutchinson Cancer Center/University of Washington, Seattle, WA, USA., Birrell SN; Wellend Health/Burnside War Memorial Hospital, Toorak Gardens, SA, Australia; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Wheelwright S; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Sussex, Falmer, Brighton, UK., Lim E; The Kinghorn Cancer Centre and Cancer Research Theme, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Schwartzberg LS; Renown Health-Pennington Cancer Institute, Reno, NV, USA., Dwyer AR; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Rugo HS; Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA., Cobb P; Cancer Centers of Montana, Billings, MT, USA., O'Shaughnessy JA; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA., Johnston S; The Breast Unit, The Royal Marsden NHS Foundation Trust, London, UK., Brufsky A; Division of Hematology/Oncology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Overmoyer B; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Mar; Vol. 25 (3), pp. 317-325. Date of Electronic Publication: 2024 Feb 08.
Zobrazit plný text záznamu
9
Akademický článek
The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
Autor: Hosseinzadeh L; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Kikhtyak Z; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Laven-Law G; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Pederson SM; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Puiu CG; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., D'Santos CS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Lim E; Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Dwyer AR; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia. theresa.hickey@adelaide.edu.au.
Publikováno v: Genome biology [Genome Biol] 2024 Feb 05; Vol. 25 (1), pp. 44. Date of Electronic Publication: 2024 Feb 05.
Zobrazit plný text záznamu
10
Akademický článek
Selective inhibition of CDK9 in triple negative breast cancer.
Autor: Mustafa EH; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Laven-Law G; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Kikhtyak Z; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Nguyen V; Department of Surgery & Cancer, Imperial College London, London, UK., Ali S; Department of Surgery & Cancer, Imperial College London, London, UK., Pace AA; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Iggo R; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.; Institut Bergonié, University of Bordeaux, Bordeaux, France., Kebede A; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Noll B; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Wang S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Winter JM; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Dwyer AR; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia. theresa.hickey@adelaide.edu.au.
Publikováno v: Oncogene [Oncogene] 2024 Jan; Vol. 43 (3), pp. 202-215. Date of Electronic Publication: 2023 Nov 24.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje